[ET Net News Agency, 11 August 2026] HANSOH PHARMA (03692) rose 5% to HK$36.28.
It hits an intra-day high of HK$36.32, hitting an 1-month high, breaking above the 250-D SMA of HK$35.672, and an intra-day low of HK$34.42. The total shares traded was 2.89 million, with a value of HK$102.87m. The active buy/sell ratio is 68:32, with net buying turnover of HK$32.04m. CHINA INNOVATION MARKET SER accounts for greatest net responsive buying turnover of HK$2.95m, with volume weighted average price of HK$35.864. ABN AMRO CLEARING HK accounts for greatest net responsive selling turnover of HK$7.24m, with volume weighted average price of HK$35.555. The stock has risen a combined 15.5% over the past 5 consecutive trading days.
The Hang Seng Index now rose 67 points, or 0.3% to 26,004; the Hang Seng China Enterprises Index now rose 36 points, or 0.4% to 8,658.
Basic Information| Nominal | 36.280 | % Chg | +5.04% |
| High | 36.320 | Low | 34.420 |
| Shares Tr | 2.89m | Turnover | 102.87m |
| 10-D SMA | 32.782 | %H.V | 37.321 |
| 20-D SMA | 32.675 | VWAP | 35.604 |
| 50-D SMA | 31.270 | RSI14 | 70.217 |
Status: Breaking above the 250-D SMA, hitting an 1-month high, active buy/sell ratio is 68:32, with net buying turnover of HK$32.04m, rising a combined 15.5% over the past 5 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 36.280 | +5.04 |
| SIHUAN PHARM (00460) | 0.910 | +0.55 |
| GRAND PHARMA (00512) | 5.355 | -0.65 |
| SBP GROUP (01177) | 5.125 | +1.49 |
| HENGRUI PHARMA (01276) | 59.000 | +1.81 |
| LIVZON PHARMA (01513) | 26.800 | +0.98 |
| LUYE PHARMA (02186) | 2.160 | +2.13 |
| FOSUN PHARMA (02196) | 17.250 | +1.17 |
| SH PHARMA (02607) | 11.920 | +0.17 |
| CHINARES PHARMA (03320) | 4.910 | +1.24 |
(ed)
